Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer

Other authors

Institut Català de la Salut

Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-08-17T11:50:51Z

2023-08-17T11:50:51Z

2023-05-30



Abstract

Tumor microenvironments; Head and neck cancer; Radiotherapy


Microambientes tumorales; Cáncer de cabeza y cuello; Radioterapia


Microambients tumorals; Càncer de cap i coll; Radioteràpia


Despite intensive efforts and refined techniques, overall survival in HPV-negative head and neck cancer remains poor. Robust immune priming is required to elicit a strong and durable antitumor immune response in immunologically cold and excluded tumors like HPV-negative head and neck cancer. This review highlights how the tumor microenvironment could be affected by different immune and stromal cell types, weighs the need to integrate metabolic regulation of the tumor microenvironment into cancer treatment strategies and summarizes the emerging clinical applicability of personalized immunotherapeutic strategies in HPV-negative head and neck cancer.

Document Type

Article


Published version

Language

English

Publisher

OAE Publishing

Related items

Cancer Drug Resistance;6

http://dx.doi.org/10.20517/cdr.2022.141

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)